Navigation

Investiment.io
Financial analysis platform

Bristol-Myers Squibb Company

BMY โ€ข NYSE

$63.33
โ–ผ0.10 (0.16%)โ€ข REGULAR

Bristol-Myers Squibb Company

$63.33
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
โš–๏ธ

Balance SheetBMY

Balance Sheet Summary

Key balance sheet metrics and financial position for BMY

๐Ÿข
Total Assets
$90,038,000
(in thousands USD)
๐Ÿ“‹
Total Liabilities
$71,533,000
(in thousands USD)
๐Ÿ‘ฅ
Shareholders' Equity
$18,473,000
(in thousands USD)
โš–๏ธ
Debt-to-Equity Ratio
2.32
Long-term Debt / Equity

Balance Sheet Analysis

Analyze assets, liabilities, and equity trends over time

Period:annual

Select Metrics to Compare (4 selected)

Total Assets Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$30.00B$60.00B$90.00B$120.00B-12%-9%-6%-3%0%
  • Total Assets
  • Total Assets YoY Growth

Total Liabilities Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$20.00B$40.00B$60.00B$80.00B-18%-9%0%+9%+18%
  • Total Liabilities
  • Total Liabilities YoY Growth

Total Shareholders' Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$9.00B$18.00B$27.00B$36.00B-45%-30%-15%0%+15%
  • Total Shareholders' Equity
  • Total Shareholders' Equity YoY Growth

Cash and Cash Equivalents Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.003500000000.007000000000.0010500000000.0014000000000.00-40%-20%0%+20%+40%
  • Cash and Cash Equivalents
  • Cash and Cash Equivalents YoY Growth